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A commentary on
Autism-related deficits via dysregulated
eIF4E-dependent translational control
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Rampakakis, E., Nevarko, T., Weatherill, D.
B., et al. (2013). Nature 493, 371–377.
Autism spectrum disorders (ASDs) are a
group of clinically and genetically het-
erogeneous neurodevelopmental disorders
characterized by impaired social interac-
tions, repetitive behaviors and restricted
interests (Baird et al., 2006; Zoghbi
and Bear, 2012). The genetic defects
in ASDs may interfere with synaptic
protein synthesis. Synaptic dysfunction
caused by aberrant protein synthesis is
a key pathogenic mechanism for ASDs
(Kelleher and Bear, 2008; Richter and
Klann, 2009; Ebert and Greenberg, 2013).
Understanding the details about aber-
rant synaptic protein synthesis is impor-
tant to formulate potential treatment for
ASDs. The mammalian target of the
rapamycin (mTOR) pathway plays central
roles in synaptic protein synthesis (Hay
and Sonenberg, 2004; Hoeffer and Klann,
2010; Hershey et al., 2012). Recently,
Gkogkas and colleagues published excit-
ing data on the role of downstream mTOR
pathway in autism (Gkogkas et al., 2013)
(Figure 1).
Previous studies have indicated that
upstream mTOR signaling is linked to
ASDs. Mutations in tuberous sclerosis
complex (TSC) 1/TSC2, neurofibromato-
sis 1 (NF1), and Phosphatase and tensin
homolog (PTEN) lead to syndromic ASD
with tuberous sclerosis, neurofibromato-
sis, or macrocephaly, respectively (Kelleher
and Bear, 2008; Bourgeron, 2009; Hoeffer
and Klann, 2010; Sawicka and Zukin,
2012). TSC1/TSC2, NF1, and PTEN act
as negative regulators of mTOR com-
plex 1 (mTORC1), which is activated by
phosphoinositide-3 kinase (PI3K) path-
way (Kelleher and Bear, 2008; Auerbach
et al., 2011; Sawicka and Zukin, 2012)
(Figure 1). Activation of cap-dependent
translation is a principal downstream
mechanism of mTORC1. The eIF4E recog-
nizes the 5′ mRNA cap, recruits eIF4G and
the small ribosomal subunit (Richter and
Sonenberg, 2005; Hershey et al., 2012).
The eIF4E-binding proteins (4E-BPs)
bind to eIF4E and inhibit translation
initiation. Phosphorylation of 4E-BPs
by mTORC1 promotes eIF4E release
and initiates cap-dependent translation
(Richter and Klann, 2009; Hoeffer and
Klann, 2010) (Figure 1). A hyperactivated
mTORC1–eIF4E pathway is linked to
impaired synaptic plasticity in fragile X
syndrome, an autistic disorder caused
by lack of fragile X mental retardation
protein (FMRP) due to mutation of the
FMR1 gene (Wang et al., 2010; Auerbach
et al., 2011; Santoro et al., 2012; Wang
et al., 2012), suggesting that downstream
mTOR signaling might be causally linked
to ASDs. Notably, one pioneering study
has identified amutation in the EIF4E pro-
moter in autism families (Neves-Pereira
et al., 2009), implying that deregulation
of downstream mTOR signaling (eIF4E)
could be a novel mechanism for ASDs.
As an eIF4E repressor downstream of
mTOR, 4E-BP2 has important roles in
synaptic plasticity, learning and mem-
ory (Banko et al., 2005; Richter and
Klann, 2009). Writing in their Nature arti-
cle, Gkogkas and colleagues reported that
deletion of the gene encoding 4E-BP2
(Eif4ebp2) leads to autistic-like behaviors
in mice. Pharmacological inhibition of
eIF4E rectifies social behavior deficits in
Eif4ebp2 knockout mice (Gkogkas et al.,
2013). Their study in mouse models has
provided direct evidence for the causal link
between dysregulated eIF4E and the devel-
opment of ASDs.
Are these ASD-like phenotypes of the
Eif4ebp2 knockout mice caused by altered
translation of a subset mRNAs due to the
release of eIF4E? To test this, Gkogkas
et al. measured translation initiation rates
and protein levels of candidate genes
known to be associated with ASDs in
hippocampi from Eif4ebp2 knockout and
eIF4E-overexpressing mice. They found
that the translation of neuroligin (NLGN)
mRNAs is enhanced in both lines of
transgenic mice. Removal of 4E-BP2 or
overexpression of eIF4E increases protein
amounts of NLGNs in the hippocampus,
whereasmRNA levels are not affected, thus
excluding transcriptional effects (Gkogkas
et al., 2013). In contrast, the authors did
not observe any changes in the translation
of mRNAs coding for other synaptic scaf-
folding proteins. Interestingly, treatment
of Eif4ebp2 knockout mice with selec-
tive eIF4E inhibitor reduces NLGN pro-
tein levels to wild-type levels (Gkogkas
et al., 2013). These data thus indicate
that relief of translational suppression by
loss of 4E-BP2 or by the overexpres-
sion of eIF4E selectively enhances the
NLGN synthesis. However, it cannot be
ruled out that other proteins (synaptic or
non-synaptic) may be affected and con-
tribute to animal autistic phenotypes.
Aberrant information processing due
to altered ratio of synaptic excitation
to inhibition (E/I) may contribute to
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FIGURE 1 | The mTOR signal pathway in autism spectrum disorders. The mTOR pathway
integrates inputs from different sources, such as NMDAR, mGluR, and RYK. Activation of mTORC1
promotes the formation of the eIF4F initiation complex. Mutations in TSC1/2, NF1, and PTEN, or loss
of FMRP due to mutations of the FMR1gene, cause hyperactivity of mTORC1–eIF4E pathway and
lead to syndromic ASDs. 4E-BP2 inhibits translation by competing with eIF4G for eIF4E binding.
Gkogkas et al. demonstrated that removal of 4E-BP2 or overexpression of eIF4E enhances
cap-dependent translation. The increased translation of NLGNs causes increased synaptic E/I ratio,
which may eventually lead to ASD phenotypes. Abbreviations: Akt, also known as PKB, protein kinase
B; ASD, autism spectrum disorder; 4E-BP2, eIF4E-binding protein 2; E/I, excitation/inhibiton; ERK,
extracellular signal regulated kinase; FMRP, fragile X mental retardation protein; MEK,
mitogen-activated protein/ERK kinase; mGluR, metabotropic glutamate receptor; mTOR, mammalian
target of rapamycin; mTORC1, mTOR complex 1; NF1, neurofibromatosis 1; NLGN, neuroligin;
NMDAR, NMDA receptor; PDK, phosphoinositide dependent kinase; PI3K, phosphoinositide-3 kinase;
PTEN, Phosphatase and tensin homolog; Raptor, regulatory associated protein of mTOR; Rheb, Ras
homolog enriched in brain; RYK, receptor-like tyrosine kinase; S6K1, p70 ribosomal S6 kinase 1; TSC,
tuberous sclerosis complex.
ASDs (Rubenstein and Merzenich, 2003;
Bourgeron, 2007; Uhlhaas and Singer,
2012). The increased or decreased E/I
ratio has been observed in ASD ani-
mal models (Chao et al., 2010; Bateup
et al., 2011; Luikart et al., 2011; Schmeisser
et al., 2012). In relation to these E/I
shifts, Gkogkas et al then examined the
synaptic transmission in hippocampal
slices of Eif4ebp2 knockout mice. They
found that 4E-BP2 de-repression results
in an increased E/I ratio, which can be
explained by the increase of vesicular
glutamate transporter and spine density
in hippocampal pyramidal neurons. As
expected, application of eIF4E inhibitor
restores the E/I balance (Gkogkas et al.,
2013).
Finally, in view of the facts that
genetic manipulation of NLGNs results in
ASD-like phenotypes with altered E/I bal-
ance in mouse models (Chubykin et al.,
2007; Tabuchi et al., 2007; Etherton et al.,
2011) and NLGN mRNA translation is
enhanced concomitant with increased E/I
ratio in Eif4ebp2 knockout mice, Gkogkas
et al. tested the effect of NLGN knock-
down on synaptic plasticity and behaviour
in these mice (Gkogkas et al., 2013).
NLGN1 is predominantly postsynaptic at
excitatory synapses and promotes excita-
tory synaptic transmission (Varoqueaux
et al., 2006; Kwon et al., 2012). The authors
found that NLGN1 knockdown reverses
changes at excitatory synapses and par-
tially rescues the social interaction deficits
in Eif4ebp2 knockoutmice (Gkogkas et al.,
2013). These findings thus established
a strong link between eIF4E-dependent
translational control of NLGNs, E/I bal-
ance and the development of ASD-like
animal behaviors (Figure 1).
In summary, Gkogkas et al. have
provided a model for mTORC1/eIF4E-
dependent autism-like phenotypes due
to dysregulated translational control
(Gkogkas et al., 2013). This novel regula-
tory mechanism will prompt investigation
of downstream mTOR signaling in ASDs,
as well as expand our knowledge of how
mTOR functions in human learning and
cognition. It may narrow down therapeu-
tic targets for autism since targeting down-
stream mTOR signaling reverses autism.
Pharmacological manipulation of down-
stream effectors of mTOR (eIF4E, 4E-BP2,
and NLGNs) may eventually provide ther-
apeutic benefits for patients with ASDs.
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